Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Cadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Pembrolizumab in Locally Advanced Sinonasal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Envafolimab Plus Docetaxel In Combination With or Without Trilaciclib Versus Docetaxel in Advanced NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
TCb vs EC-T in High Risk ER+/HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of KN026 in Combination With HB1801 in the First-line Treatment of Subjects With HER2-positive Recurrent or Metastatic Breast Cancer.
- Status
- RECRUITING
- Phase
- PHASE3
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.
- Status
- COMPLETED
- Phase
- N/A
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1